Digitalis Ventures: Investment Portfolio & Startup News
Digitalis Ventures
To add a bio or update investment portfolio, please click update information.
Investment Portfolio
Omni Pet
22 Jun 2026
Omni Pet secures £11m in funding led by IW Capital for veterinary-grade protein nutrition for dogs
Omni Pet is a science-led pet health company that develops calorie-controlled, novel protein foods, treats and supplements for dogs, replacing common allergens such as beef, chicken and dairy with yeast, algae and pulse-based alternatives. Founded by a practising veterinarian, the brand targets dogs with obesity, food allergies and gut sensitivities, and provides round-the-clock vet access to pet owners.
T-Therapeutics
13 Nov 2025
T-Therapeutics secures £24m Series A extension with Tencent and BGF to develop T cell receptor therapeutics for cancer and autoimmune disease
T-Therapeutics develops next-generation T cell receptor therapies designed to target cancer and autoimmune disease, advancing bispecific molecules that selectively remove disease-driving immune cells while preserving healthy function.
Digitalis Ventures
More venture news
- 30 Sept 2026
ZenithonZenithon raises a £7.5m seed round led by BACKED for ML models that solves complex physics
EquityDeep Tech - 30 Sept 2026
Inovus MedicalInovus Medical lands £7m extension led by PXN Group to provide surgeons with surgical simulation training
EquityHealth - 29 Sept 2026
Something & NothingSomething & Nothing unlocks £5m in funding led by Venrex for premium soft drinks built on flavour
EquityConsumer
